PAN joins Alliance for Connected Care urging extension on DEA telemedicine flexibilities

The PAN Foundation joined more than 300 healthcare and health advocacy organizations in a letter urging Congress to ensure ongoing access to virtual prescribing for patients and providers of certain controlled substances. The Drug Enforcement Administration (DEA) is anticipated to dramatically limit virtual prescribing, either through new regulations or by allowing the existing flexibilities to expire. Telehealth flexibility has been essential in ensuring that patients receive timely and necessary care. Continuing these practices is vital to sustaining access to treatment and addressing the ongoing health care challenges, particularly in underserved areas.